Canal Insurance CO

Insurance

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1313473 Greenville, SC

Position in NTLA

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$2,948,600

+$2,049,600 QoQ

Shares Held

230,000

+130.0% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Canal Insurance CO holds $7,388,707 across 5 Biotechnology names. NTLA ranks #1 (39.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTLA	Intellia Therapeutics, Inc. This page	230,000	$2,948,600
2	CRSP	CRISPR Therapeutics AG	35,100	$1,669,707
3	RPRX	Royalty Pharma plc	20,000	$959,400
4	BEAM	Beam Therapeutics Inc.	40,000	$953,200
5	EXEL	Exelixis, Inc.	20,000	$857,800

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,948,600	230,000	+130.0%	Shares	Sole	2026-05-04
2025-12-31	$899,000	100,000	—	Shares	Sole	2026-02-03
No filing history on record for this holder in this stock.